Cancer Family
Esophageal Neoplasm
CI-CAN-00000174Explore in graph →
Non-malignant555 active trials6 approved drugs12 evidence items
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000174Explore in graph →
Clinical trials
2,208 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00160030 | Study Comparing Radiochemotherapy With Folfox 4 Regimen or 5FU-Cisplatin in Patients With Inoperable Esophageal Cancer | completed | Phase 2 | 97 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00259402 | Oxaliplatin in Esophagus Cancer (Advanced) 1st Line | completed | Phase 2 | 41 | SanofiINDUSTRY | 1 | Dec 7, 2009 | clinicaltrials |
| NCT00681330 |
| Histocompatibility Leukocyte Antigen (HLA)-A*2402 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer |
| completed |
| Phase 1 / Phase 2 |
| 14 |
| Tokyo UniversityOTHER |
| 1 |
| Nov 19, 2009 |
| clinicaltrials |
| NCT00681421 | Histocompatibility Leukocyte Antigen (HLA)-A*0201 Restricted Peptide Vaccine Therapy in Patients With Esophageal Cancer | completed | Phase 1 / Phase 2 | 14 | Tokyo UniversityOTHER | 1 | Nov 19, 2009 | clinicaltrials |
| NCT00344552 | Phase II Study of Weekly Paclitaxel (BMS-181339)in Patients With Advanced or Recurrent Esophageal Cancer | completed | Phase 2 | 53 | Bristol-Myers SquibbINDUSTRY | 1 | Nov 13, 2009 | clinicaltrials |
| NCT00995358 | A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer | unknown | Phase 2 | 60 | University of YamanashiOTHER | 1 | Oct 15, 2009 | clinicaltrials |
| NCT00165191 | Doxorubicin, Cisplatin, 5-Fluorouracil in Patients With Advanced Adenocarcinoma of the Stomach or Esophagus | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00165464 | Taxotere, Cisplatin and Irinotecan (CPT-11) for Esophagogastric Cancer | completed | Phase 2 | 54 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00215462 | Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma | completed | Phase 2 | 32 | Dana-Farber Cancer InstituteOTHER | 1 | Apr 28, 2009 | clinicaltrials |
| NCT00197444 | Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer | completed | Phase 2 | 33 | Hamamatsu UniversityOTHER | 1 | Feb 20, 2009 | clinicaltrials |
| NCT00008047 | Combination Chemotherapy Combined With Radiation Therapy in Treating Patients Who Have Stage II or Stage III Cancer of the Esophagus | unknown | Phase 1 / Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Feb 9, 2009 | clinicaltrials |
| NCT00759226 | Chemotherapeutic Trial With Gemcitabine, Cisplatin, 5-FU and Folinic Acid in Esophageal Cancer(CONKO-101) | completed | Phase 2 | 92 | CONKO-StudiengruppeOTHER | 1 | Sep 26, 2008 | clinicaltrials |
| NCT00239200 | Lapatinib (GW572016) for Metastatic or Recurrent Squamous Cell Carcinoma Esophagus | terminated | Phase 2 | 29 | University of Michigan Rogel Cancer CenterOTHER | 1 | Jul 30, 2008 | clinicaltrials |
| NCT00003326 | Paclitaxel in Treating Patients With Metastatic, Recurrent, or Unresectable Cancer of the Esophagus | unknown | Phase 2 | 100 | TheradexINDUSTRY | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00075738 | Fluorouracil, Irinotecan, Leucovorin, and Cisplatin as First-Line Therapy in Treating Patients With Metastatic Esophageal Cancer | unknown | Phase 2 | — | GERCOR - Multidisciplinary Oncology Cooperative GroupOTHER | 1 | Jul 24, 2008 | clinicaltrials |
| NCT00477841 | Self-Expandable Esophageal Radiation Stent:a Randomized Controlled Trial in Patients With Advanced Esophageal Cancer | completed | Phase 2 | 60 | Southeast University, ChinaOTHER | 1 | Apr 18, 2008 | clinicaltrials |
| NCT00154804 | CCRT With Twice Weekly Paclitaxel and Cisplatin Followed by Surgery for Locally Advanced Esophageal Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Aug 23, 2007 | clinicaltrials |
| NCT00054873 | Tezacitabine With or Without 5-Fluorouracil (5-FU) for Advanced Esophageal Cancer or Gastric Cancer | completed | Phase 2 | — | Chiron CorporationINDUSTRY | 1 | Jul 11, 2006 | clinicaltrials |
| NCT00197431 | Pharmacokinetic and Pharmacodynamic Study of S-1 in Patients With Digestive Organ Cancer | unknown | Phase 2 | — | Hamamatsu UniversityOTHER | 1 | Mar 22, 2006 | clinicaltrials |
| NCT00154700 | Twice Weekly TP-HDFL for Recurrent or Metastatic Esophageal Cancer | completed | Phase 2 | 40 | National Taiwan University HospitalOTHER | 1 | Dec 20, 2005 | clinicaltrials |
| NCT00139633 | Selective Dose Escalation for Esophageal Cancer | unknown | Phase 2 | 25 | The Oregon ClinicOTHER | 1 | Aug 31, 2005 | clinicaltrials |
| NCT00037089 | A Phase II Study of Paclitaxel, UFT, and Leucovorin in Patients With Metastatic Esophageal Cancer | unknown | Phase 2 | — | Edelman, Martin, M.D.INDIV | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00041808 | Magnetic-Targeted Doxorubicin in Treating Patients With Cancer Metastatic to the Liver | completed | Phase 1 / Phase 2 | 20 | FeRxINDUSTRY | 2 | Jun 24, 2005 | clinicaltrials |
| NCT00048529 | Study of T900607-Sodium in Subjects With Previously Treated Gastric Cancer or Adenocarcinoma of the Esophagus | suspended | Phase 2 | 70 | TularikINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
| NCT00057395 | A Safety and Effectiveness Study of Aroplatin in Patients With Advanced Solid Malignancies | unknown | Phase 1 / Phase 2 | 40 | Aronex PharmaceuticalsINDUSTRY | 1 | Jun 24, 2005 | clinicaltrials |
Data updated 22 days agoSource updated Dec 7, 2009source: clinicaltrials